We only have this paper's title and publication details.
Read it at the sourcePhase IB trial assesses efficacy and safety of binimetinib and palbociclib in patients with advanced triple-negative breast cancer, highlighting participant representativeness.
Representativeness of Study Participants table
No takes yet. Share an insight, caveat, or question.
Manso et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: